Loading company…
Massachusetts biotech developing macrophage checkpoint modulators for cancer, immune and inflammatory diseases.
Verseau Therapeutics develops therapeutics for cancer, immune and inflammatory diseases, with a focus on macrophage checkpoint modulators for immunotherapy. Founded in 2017 and based in Massachusetts, US, the company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in